Safety of oil from Schizochytrium sp. A2 for use in infant and follow‐on formula as a novel food pursuant to regulation (EU) 2015/2283
EFSA Journal · 01.05.2026 · 24 (5) · e10097-e10097
DOI: 10.2903/j.efsa.2026.10097 ↗Kurz gefasst
Fachartikel in der Zeitschrift EFSA Journal, erschienen am 01.05.2026. Verfasst von EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) und 21 weiteren Autor:innen. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the safety of an oil derived from the microalga‐like organism Schizochytrium sp. A2 as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The oil is a mixture of triglycerides in which docosahexaenoic acid (DHA) represents around 40% of total fatty acids. The applicant proposes the use of the NF as an ingredient in infant formula and follow‐on formula and in food supplements for adults (excluding pregnant and lactating women), at a maximum intake of 3 g DHA per day. The evidence provided by the applicant does not allow the determination of the species to which Schizochytrium sp. A2 belongs. Although batch analyses showed that tested marine biotoxins were below their respective limits of quantification, since it is unknown to which species the production strain belongs, the concern that the strain Schizochytrium sp. A2 has the potential to produce other toxins than those tested remains. Due to the unresolved taxonomic identity of the production strain, the qualified presumption of safety qualification of the production strain cannot be used in the safety assessment of this NF. Furthermore, no toxicological studies conducted with the NF itself were submitted. While toxicological data exist for DHA‐rich algal oils derived from other Schizochytrium strains, these cannot be used to establish the safety of the oil produced from strain A2. The Panel concludes that, based on the available data, the safety of the NF (oil produced from Schizochytrium sp. A2) cannot be established.
Schlagwörter
Stichwörter der Autor:innen
Zitieren
APA
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Turck, D., Bohn, T., Cámara, M., Castenmiller, J., De Henauw, S., Jos, Á., Maciuk, A., Mangelsdorf, I., McNulty, B., Naska, A., Pentieva, K., Siani, A., Thies, F., Frenzel, T., Aguilera-Gómez, M., Marcon, F., Neuhäuser-Berthold, M., Nuin Garciarena, I., …, & Hirsch-Ernst, K. I. (2026). Safety of oil from Schizochytrium sp. A2 for use in infant and follow‐on formula as a novel food pursuant to regulation (EU) 2015/2283. EFSA Journal, 24(5), e10097-e10097. https://doi.org/10.2903/j.efsa.2026.10097
Vancouver
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Turck D, Bohn T, Cámara M, Castenmiller J, De Henauw S, et al. Safety of oil from Schizochytrium sp. A2 for use in infant and follow‐on formula as a novel food pursuant to regulation (EU) 2015/2283. EFSA Journal. 2026;24(5):e10097-e10097. doi:10.2903/j.efsa.2026.10097
BibTeX
@article{EFSAPanelonNutritionNovelFoodsandFoodAllergensNDA2026,
author = {EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) and Turck, Dominique and Bohn, Torsten and Cámara, Montaña and Castenmiller, Jacqueline and De Henauw, Stefaan and Jos, Ángeles and Maciuk, Alexandre and Mangelsdorf, Inge and McNulty, Breige and Naska, Androniki and Pentieva, Kristina and Siani, Alfonso and Thies, Frank and Frenzel, Thomas and Aguilera-Gómez, Margarita and Marcon, Francesca and Neuhäuser-Berthold, Monika and Nuin Garciarena, Irene and Turla, Emanuela and Favata, Areti and Hirsch-Ernst, Karen Ildico},
title = {Safety of oil from Schizochytrium sp. A2 for use in infant and follow‐on formula as a novel food pursuant to regulation (EU) 2015/2283},
journal = {EFSA Journal},
year = {2026},
volume = {24},
number = {5},
pages = {e10097--e10097},
doi = {10.2903/j.efsa.2026.10097}
}
EUVIMED